Conditions: Influenza A
Keywords: efficacy safety
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 81
Healthy volunteers: yes

Brief summary:
This study is to evaluate the efficacy of CT-P27 measured by quantitative PCR viral load from nasopharyngeal mucosa, compared to placebo.

Detailed description:
This study is a Randomised, Double-Blind, Placebo-Controlled, Single-Centre, Phase IIa study. All enrolled subjects will be given a single dose of 10 mg/kg CT-P27, 20 mg/kg CT-P27, or placebo intravenously and then followed by Day 36.

Arms:
arm 1: CT-P27 will be administrated once in IV infusion. arm 2: CT-P27 will be administrated once in IV infusion. arm 3: Placebo will be administrated once in IV infusion.

Interventions: intervention 1: CT-P27 intervention 2: Placebo
Intervention descriptions: intervention 1: Influenza A treatment drug. intervention 2: Placebo.

Protocol document: